Cargando…
Safety and efficacy of vemurafenib in end stage renal failure
BACKGROUND: Serine-threonine inhibitors, such as vemurafenib, are being used increasingly in cancer treatment, and the toxicity and therapeutic benefit need to be balanced carefully both before and during treatment. CASE PRESENTATION: A patient with metastatic melanoma and end stage renal failure wh...
Autores principales: | Iddawela, Mahesh, Crook, Sarah, George, Leah, Lakkaraju, Amit, Nanayakkara, Nihal, Hunt, Roland, Adam, William R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029063/ https://www.ncbi.nlm.nih.gov/pubmed/24314265 http://dx.doi.org/10.1186/1471-2407-13-581 |
Ejemplares similares
-
A Rare Cause of Uveitis: Vemurafenib
por: Sızmaz, Selçuk, et al.
Publicado: (2018) -
Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
por: Sahadudheen, K., et al.
Publicado: (2016) -
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023) -
End-stage renal failure associated with congenital deafness
por: Annear, Nicholas M P, et al.
Publicado: (2008) -
Emphysematous pyelonephritis leading to end-stage renal failure
por: Simms, Roslyn, et al.
Publicado: (2008)